Profile
Join date: Nov 2, 2020
Posts
Feb 1, 2021 ∙ 3 min
The Case for Supernus Pharmaceuticals
Supernus Pharmaceuticals is a small(ish)-cap specialty pharmaceuticals company that is largely involved in neuroscience and psychiatry....
24
0
Nov 19, 2020 ∙ 3 min
Aducanumab takes Biogen stock for a wild ride
Aducanumab is a monoclonal antibody that selectively targets and decreases levels of the amyloid beta plaques that are a hallmark of...
53
0
Chris Biser
Writer
More actions